You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Negative Impacts of the Pharmaceutical Affairs Act-Patent Linkage System
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-SAP-018
- By: WU, Chung-Fu (China Chemical & Pharmaceutical Ltd. (CCPC), R&D, China Taiwan)
- Co-author(s): Chung-Fu Wu: R&D, China Chemical & Pharmaceutical Ltd. (CCPC), Taipei, Taiwan, Province of China;, Taipei Pharmacists Association, TAIPEI, Taiwan, Province of China
- Abstract:
Background
Patents grant an inventor the right to exclude others from making, using, or selling their invention. In Taiwan (TW), the revision to the Pharmaceutical Affairs Act to accommodate Patent Linkage (PAA-PL) was passed in 2017, and implementation rules went into force on August 20 2019.
Purpose
To confirm whether industries benefit from
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026